Literature DB >> 3883799

Relationship between degree of obesity and in vivo insulin action in man.

C Bogardus, S Lillioja, D M Mott, C Hollenbeck, G Reaven.   

Abstract

Previous studies have demonstrated reduced in vivo insulin action in obese subjects compared with lean controls. However, little data is available on the relationship between degree of obesity and insulin action, and this relationship has not been shown to be independent of individual differences in maximal aerobic capacity. We studied 55 male Pima Indians and 35 male Caucasians with normal glucose tolerance. In vivo insulin action was measured using the hyperinsulinemic, euglycemic clamp technique at a plasma insulin concentration of approximately 100 microU/ml. Body composition was determined by densitometry, and maximal aerobic capacity was estimated using a graded exercise test. The results showed that degree of obesity was nonlinearly related to in vivo insulin action. In both Indians and Caucasians there was a significant decline in insulin action with increasing obesity up to a percent body fat of approximately 28-30%. Further increases in obesity in the Indians were not associated with significant changes in insulin action. Maximal aerobic capacity was positively linearly correlated with insulin action over the entire range of insulin action in both racial groups. Degree of obesity and maximal aerobic capacity were each independently associated with insulin action although these independent relationships were of marginal significance in the Caucasians. Surprisingly, individual differences in obesity and maximal aerobic capacity accounted for only half the variability observed in insulin action in these glucose tolerant subjects.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3883799     DOI: 10.1152/ajpendo.1985.248.3.E286

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  56 in total

Review 1.  Diet and Syndrome X.

Authors:  G M Reaven
Journal:  Curr Atheroscler Rep       Date:  2000-11       Impact factor: 5.113

2.  Identification of differentially expressed genes in skeletal muscle of non-diabetic insulin-resistant and insulin-sensitive Pima Indians by differential display PCR.

Authors:  Y H Lee; S Tokraks; R E Pratley; C Bogardus; P A Permana
Journal:  Diabetologia       Date:  2003-10-24       Impact factor: 10.122

Review 3.  The insulin resistance syndrome.

Authors:  Gerald M Reaven
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

Review 4.  Surgical treatment of obesity.

Authors:  Nancy Puzziferri; Jeanne Blankenship; Bruce M Wolfe
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

5.  Insulin resistance in pulmonary arterial hypertension.

Authors:  R T Zamanian; G Hansmann; S Snook; D Lilienfeld; K M Rappaport; G M Reaven; M Rabinovitch; R L Doyle
Journal:  Eur Respir J       Date:  2008-12-01       Impact factor: 16.671

Review 6.  Reduced physical activity and risk of chronic disease: the biology behind the consequences.

Authors:  Frank W Booth; Matthew J Laye; Simon J Lees; R Scott Rector; John P Thyfault
Journal:  Eur J Appl Physiol       Date:  2007-11-07       Impact factor: 3.078

7.  Independent effects of obesity and insulin resistance on postprandial thermogenesis in men.

Authors:  K R Segal; J Albu; A Chun; A Edano; B Legaspi; F X Pi-Sunyer
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

8.  Relationship between body mass index and insulin resistance in patients treated with second generation antipsychotic agents.

Authors:  Sun H Kim; Lilla Nikolics; Fahim Abbasi; Cindy Lamendola; James Link; Gerald M Reaven; Steven Lindley
Journal:  J Psychiatr Res       Date:  2009-12-03       Impact factor: 4.791

9.  Splanchnic insulin metabolism in obesity. Influence of body fat distribution.

Authors:  A N Peiris; R A Mueller; G A Smith; M F Struve; A H Kissebah
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

10.  Determinants of 24-hour energy expenditure in man. Methods and results using a respiratory chamber.

Authors:  E Ravussin; S Lillioja; T E Anderson; L Christin; C Bogardus
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.